Pfizer Healthcare
Pfizer Healthcare is the pharmaceutical brand of Pfizer Inc., a global biopharmaceutical company.
Last updated October 30, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Pfizer Healthcare is the pharmaceutical brand of Pfizer Inc., one of the world's largest biopharmaceutical companies. Founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York, Pfizer began as a chemicals business and grew into a global pharmaceutical leader through a combination of internal research, strategic acquisitions, and worldwide commercialization. The company is headquartered in New York City and is listed on the New York Stock Exchange under the ticker PFE. Pfizer Healthcare's portfolio spans innovative medicines and vaccines across therapeutic areas such as oncology, immunology, cardiology, neurology, and infectious diseases, as well as consumer health products. The brand is known for blockbuster products and for its role in developing and manufacturing vaccines and treatments during global health crises. Pfizer operates in markets around the world and invests heavily in research and development. As a corporate brand, Pfizer Healthcare represents the company's commitment to science-driven innovation and public health. Its positioning emphasizes research excellence, global reach, and a broad product pipeline. The brand has undergone significant portfolio changes, including the spin-off of its Upjohn business and the acquisition of Seagen, reflecting a strategic focus on high-growth innovative therapies.
History
Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York, as a manufacturer of fine chemicals. The company initially produced chemicals such as santonin and later expanded into pharmaceuticals. In the 20th century, Pfizer became a major producer of penicillin during World War II and subsequently developed a broad portfolio of prescription medicines. The company established itself as a global pharmaceutical leader through blockbuster drugs like Lipitor and Viagra. In recent decades, Pfizer has pursued major acquisitions, including Warner-Lambert, Pharmacia, and Wyeth, to expand its product pipeline and global reach. In 2019, Pfizer spun off its Upjohn business, which merged with Mylan to form Viatris. In 2020-2021, Pfizer developed and commercialized a COVID-19 vaccine in partnership with BioNTech, significantly raising its global profile. In 2023, Pfizer acquired Seagen, a biotechnology company focused on oncology, for approximately $43 billion. The company continues to invest in research and development across multiple therapeutic areas.
- 2023
Acquired Seagen for approximately $43 billion.
- 2020
Partnered with BioNTech to develop a COVID-19 vaccine.
- 2019
Spun off Upjohn business, which merged with Mylan to form Viatris.
- 2009
Acquired Wyeth.
- 2003
Acquired Pharmacia.
- 2000
Acquired Warner-Lambert.
- 1940
Became a major producer of penicillin during World War II.
- 1849
Founded by Charles Pfizer and Charles Erhart in Brooklyn, New York.
Products and positioning
Science-driven global biopharmaceutical leader focused on innovative medicines and vaccines.
Comirnaty (COVID-19 vaccine)
COVID-19 vaccine developed with BioNTech.
Lipitor (atorvastatin)
Statin for cholesterol management.
Viagra (sildenafil)
Treatment for erectile dysfunction.
Prevnar 13
Pneumococcal conjugate vaccine.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/pfizer-healthcare · Editorial policy · How profiles are compiled